What have you always wondered about the economy? Tell us

Why rare-disease treatments can be big business

Jan 11, 2016
Combined, Shire and Baxalta expect 65 percent of total revenue to come from rare disease treatments.

Drug company's subsidies to patients under review

Oct 15, 2015
Assistance programs are also marketing tools that can raise overall costs.